Coll_2006_Eur.J.Pharmacol_544_104

Reference

Title : Effects of rosiglitazone and metformin on postprandial paraoxonase-1 and monocyte chemoattractant protein-1 in human immunodeficiency virus-infected patients with lipodystrophy - Coll_2006_Eur.J.Pharmacol_544_104
Author(s) : Coll B , van Wijk JP , Parra S , Castro Cabezas M , Hoepelman IM , Alonso-Villaverde C , de Koning EJ , Camps J , Ferre N , Rabelink TJ , Tous M , Joven J
Ref : European Journal of Pharmacology , 544 :104 , 2006
Abstract : Coll_2006_Eur.J.Pharmacol_544_104
ESTHER : Coll_2006_Eur.J.Pharmacol_544_104
PubMedSearch : Coll_2006_Eur.J.Pharmacol_544_104
PubMedID: 16843455

Related information

Citations formats

Coll B, van Wijk JP, Parra S, Castro Cabezas M, Hoepelman IM, Alonso-Villaverde C, de Koning EJ, Camps J, Ferre N, Rabelink TJ, Tous M, Joven J (2006)
Effects of rosiglitazone and metformin on postprandial paraoxonase-1 and monocyte chemoattractant protein-1 in human immunodeficiency virus-infected patients with lipodystrophy
European Journal of Pharmacology 544 :104

Coll B, van Wijk JP, Parra S, Castro Cabezas M, Hoepelman IM, Alonso-Villaverde C, de Koning EJ, Camps J, Ferre N, Rabelink TJ, Tous M, Joven J (2006)
European Journal of Pharmacology 544 :104